Xuehao Wang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0002-6050-3385

发表论文 14 篇 · 总被引 64 次 · h-index 5

代表论文

• O-GlcNAcylation of YBX1 drives a glycolysis-histone lactylation feedback loop in hepatocellular carcinoma (2025 · Cancer Letters · 被引 21)
• Evaluation of nodal status in intrahepatic cholangiocarcinoma: a population-based study (2021 · Annals of Translational Medicine · 被引 20)
• Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis (2022 · Annals of Translational Medicine · 被引 9)
• Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma (2021 · Journal of Oncology · 被引 7)
• Macrophages Atp6v0d2 regulates XBP1-mediated cholesterol metabolism to suppress metabolic dysfunction-associated steatohepatitis progression (2025 · International Immunopharmacology · 被引 6)
• Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial. (2025 · Journal of Clinical Oncology · 被引 1)